These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6162606)

  • 21. Delayed hypersensitivity and transfer factor in experimental coccidioidomycosis.
    Likholetov SM
    Sabouraudia; 1979 Sep; 17(3):251-9. PubMed ID: 93786
    [No Abstract]   [Full Text] [Related]  

  • 22. Serial transfer of delayed hypersensitivity with dialyzable transfer factor.
    Kirkpatrick CH; Smith TK
    Cell Immunol; 1976 Dec; 27(2):323-7. PubMed ID: 795550
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of the transfer factor in transplantation immunology].
    Sakharov PP; Kudrina GP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):13-6. PubMed ID: 375633
    [No Abstract]   [Full Text] [Related]  

  • 24. Bovine dialyzable lymph node extracts have antigen-dependent and antigen-independent effects on human cell-mediated immunity in vitro.
    Wilson GB; Newell RT; Burdash NM
    Cell Immunol; 1979 Sep; 47(1):1-18. PubMed ID: 315822
    [No Abstract]   [Full Text] [Related]  

  • 25. Properties and activities of transfer factor.
    Kirkpatrick CH
    J Allergy Clin Immunol; 1975 Jun; 55(6):411-21. PubMed ID: 48524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular (T cell) immunity in the human newborn.
    Stiehm ER; Winter HS; Bryson YJ
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):814-21. PubMed ID: 159431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfer of delayed hypersensitivity to nonsensitive human leukocytes with rhesus-monkey lymphoid RNA extracts.
    Paque RE; Dray S
    Transplant Proc; 1974 Jun; 6(2):203-7. PubMed ID: 4208757
    [No Abstract]   [Full Text] [Related]  

  • 28. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part II. Reconstituting effects dialyzable leukocyte lysates. (Second of three parts).
    Schindler TE; Baram P
    Allergol Immunopathol (Madr); 1980; 8(2):125-9. PubMed ID: 7457287
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.
    Gottlieb AA; Maziarz GA; Tamaki N; Sutcliffe SB
    J Immunol; 1980 Feb; 124(2):885-92. PubMed ID: 7356716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfer factor and its clinical application.
    Schulkind ML; Ayoub EM
    Adv Pediatr; 1980; 27():89-115. PubMed ID: 7013447
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical analysis of dialyzable leukocyte extracts.
    Gottlieb AA; Saito K; Sutcliffe S; Foster LA; Tamaki N; Maziarz G; Sutherland C; Brennessel B
    J Reticuloendothel Soc; 1977 Jun; 21(6):403-16. PubMed ID: 886545
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental studies on tuberculin hypersensitivity--immunological significance of leucocyte migration inhibitory factor (LIF) and macrophage migration inhibitory factor (MIF) (author's transl)].
    Matsui Y; Oshima S
    Kekkaku; 1979 Jun; 54(6):331-44. PubMed ID: 388018
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro assay for responsiveness of lymphocytes to transfer factor by a new leukocyte migration inhibitory test.
    Miyagawa Y; Kawasaki A; Komiyama A; Akabane T
    Microbiol Immunol; 1978; 22(11):701-10. PubMed ID: 370507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A quantitative study of the glia of the Purkinje cell layer of the cerebellum in mammals.
    Mann DM; Yates PO
    Neuropathol Appl Neurobiol; 1979; 5(1):71-6. PubMed ID: 107465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy with dialyzable leukocyte extracts and studies of their antigen-specific (transfer factor) activity.
    Fudenberg HH; Wilson GB; Smith CL
    Proc Virchow Pirquet Med Soc; 1980 Dec; 34():3-87. PubMed ID: 6270691
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
    Hashimoto Y; Sekiguchi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage migration inhibitory factor (MIF) in guinea pigs and humans with delayed hypersensitivity.
    Kaneko F
    J Dermatol; 1975 Sep; 2(3):115-26. PubMed ID: 1107386
    [No Abstract]   [Full Text] [Related]  

  • 38. Chorioretinitis with a combined defect in T and B lymphocytes and granulocytes. A new syndrome successfully treated with dialyzable leukocyte extracts (transfer factor).
    Kyong CU; Wilson GB; Fudenberg HH; Goust JM; Richardson P; Echerd J
    Am J Med; 1980 Jun; 68(6):955-61. PubMed ID: 6992573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract]   [Full Text] [Related]  

  • 40. Migration inhibition and stimulation factors produced from peripheral blood lymphocyte cultures of sensitised guinea pigs.
    Matsui Y; Oshima S
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):151-5. PubMed ID: 3907650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.